Pazoo, Inc. is a health and wellness company. The Company is engaged in providing infrastructure and analytical services to legally authorized distributors and producers of organic medicines and to regulators tracking their operations. Its line of business relating to and revolving around the cannabis industry. It holds an interest in MA & Associates LLC, a testing lab providing laboratory testing of cannabis.

Employees

Sector

Healthcare Facilities & Services

More about the company

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI

Market Cap	1.07M 935K 862K 807K 1.51M 101M 1.55M 10.36M 4.01M 49.74M 4.01M 3.92M 172M	P/E 2016	-0.01x	P/E 2017	-0.03x
Enterprise Value	4.11M 3.61M 3.32M 3.11M 5.84M 388M 5.96M 39.96M 15.46M 192M 15.45M 15.11M 665M	EV / Sales 2016	127x	EV / Sales 2017	-
Free-Float	99.91%	Yield 2016 *	-	Yield 2017	-

22-10-27	Mark Sarna entered into a Letter of Intent to acquire a 20% stake in MA & Associates, LLC from Pazoo, Inc. for $0.995747 million.	CI
20-09-09	An unknown buyer acquired an additional 10% stake in MA & Associates, LLC from Pazoo, Inc. for $0.23 million.	CI
17-12-30	An undisclosed buyer completed the acquisition of 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO).	CI
17-11-29	An undisclosed buyer entered into an agreement to acquire 70% membership interests in MA & Associates LLC from Pazoo, Inc. (OTCPK : PZOO) for $1.5 million.	CI
17-09-15	Pazoo, Inc. Announces Executive Changes	CI
17-04-03	Pazoo, Inc. cancelled the transaction announced on April 4, 2014	CI
16-07-14	Pazoo, Inc Implements New Validating of Testing	CI
16-06-18	Industrial Hemp and Medical Marijuana Consulting Company Signs Agreement with Pazoo	CI
16-04-26	Pazoo, Inc. will Change its Ticker to PZOO from PZOOD	CI
16-03-30	Pazoo, Inc. will Change its Ticker to PZOO from PZOO.D	CI
16-03-15	Pazoo, Inc. Receives Second Six Figure Loan from Two Individual Investors	CI
15-11-09	Pazoo Begins Generating Consulting Based Revenue with the Signing of Operational Advisory Agreement for Denver Colorado Testing Lab	CI
15-07-09	Pazoo, Inc. Signs Distribution Agreement with Pure Grow Systems, LLC	CI

22-10-28	PAZOO, INC. : Entry into a Material Definitive Agreement (form 8-K)	AQ
20-12-07	PAZOO : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	AQ
18-11-14	Pazoo : Posts Conference Call Recording	PR
18-10-31	Pazoo, Inc. : Will Hold Conference Call Thursday November 8, 2018/Pazoo Website Back Up	PR
18-10-11	Pazoo : MA & Associates LLC Accepts First Samples and Begins Testing	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NATERA, INC.	+0.45%	+13.18%	+55.74%	+425.40%	37.51B
LABCORP HOLDINGS INC.	+1.93%	+6.12%	+5.64%	+14.94%	22.26B
SONIC HEALTHCARE LIMITED	-0.78%	+1.85%	-22.53%	-41.17%	6.97B
RADNET, INC.	+1.22%	+13.03%	+4.63%	+85.41%	4.78B
DR. LAL PATHLABS LIMITED	+1.76%	+3.26%	+22.88%	+55.93%	2.99B
GENEDX HOLDINGS CORP.	+1.67%	+18.32%	-22.07%	+1,097.60%	2.07B
NEOGENOMICS, INC.	+3.20%	+27.31%	+97.91%	-12.69%	1.85B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-4.74%	+3.56%	+30.73%	-26.70%	1.7B
FLEURY S.A.	+2.63%	+4.55%	+21.57%	-1.01%	1.64B
Average	+0.82%	+8.98%	+21.61%	+177.52%	9.08B
Weighted average by Cap.	+0.87%	+9.70%	+29.02%	+229.71%

Pazoo Inc Stock Other OTC

Stocks

US70454Q2057

Healthcare Facilities & Services

Valuation: Pazoo Inc

Latest news : Pazoo Inc

Press Releases: Pazoo Inc

Managers and Directors: Pazoo Inc

Medical & Diagnostic Laboratories

Financials

Company Profile

	2016	2017
Net sales	30.52K 26.76K 24.66K 23.09K 43.3K 2.88M 44.19K 296K 115K 1.42M 115K 112K 4.93M	-
Net income	-8.8M -7.71M -7.11M -6.66M -12.48M -830M -12.74M -85.44M -33.06M -410M -33.03M -32.31M -1.42B	-3.54M -3.11M -2.86M -2.68M -5.03M -334M -5.13M -34.43M -13.32M -165M -13.31M -13.02M -573M
Net Debt	3.44M 3.02M 2.78M 2.61M 4.89M 325M 4.99M 33.46M 12.95M 161M 12.93M 12.65M 557M	3.05M 2.67M 2.46M 2.31M 4.32M 287M 4.41M 29.59M 11.45M 142M 11.44M 11.19M 493M

End-of-day quote Other OTC Other stock markets
- ^USD	-